Literature DB >> 34263326

Successful Treatment of Acquired Vulvar Lymphangiectasia with 1% Polidocanol Sclerotherapy.

Carolyn M Stull1, Uros Rakita, Luke Wallis, Aleksandar Krunic.   

Abstract

Entities:  

Keywords:  lymphangioma circumscriptum; polidocanol; sclerotherapy; vulva; lymphangiectasia

Mesh：

Substances：

Year:  2021        PMID： 34263326      PMCID： PMC9413779          DOI： 10.2340/00015555-3876

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN： 0001-5555            Impact factor:   3.875


× No keyword cloud information.
  6 in total

1.  A case of unresectable lymphangioma circumscriptum of the vulva successfully treated with OK-432 in childhood.

Authors:  Soo-Jin Ahn; Sung-Eun Chang; Jee-Ho Choi; Kee-Chan Moon; Jai-Kyoung Koh; Dae-Yeon Kim
Journal:  J Am Acad Dermatol       Date:  2006-11       Impact factor: 11.527

2.  Vulvar lymphangioma circumscriptum: comparison of primary and acquired forms in a cohort of 57 patients.

Authors:  L Simon; P Trévidic; P Denis; S Vignes
Journal:  J Eur Acad Dermatol Venereol       Date:  2017-08-13       Impact factor: 6.166

3.  Treatment of lymphangioma circumscriptum with sclerotherapy: an ignored effective remedy.

Authors:  Khalid M AlGhamdi; Thamer F Mubki
Journal:  J Cosmet Dermatol       Date:  2011-06       Impact factor: 2.696

4.  Combination technique of radiofrequency ablation with sclerotherapy in acquired lymphangiectasis of the vulva.

Authors:  Niti Khunger
Journal:  J Cutan Aesthet Surg       Date:  2009-01

5.  Vulvar Lymphangioma Circumscriptum Treated With Fractional Ablative Erbium: Yttrium Aluminium Garnet Laser.

Authors:  Joy Makdisi; Sebastien de Feraudy; Christopher B Zachary
Journal:  Dermatol Surg       Date:  2018-08       Impact factor: 3.398

6.  Clinical outcomes of primary surgical treatment for acquired vulvar lymphangioma circumscriptum.

Authors:  Gun Yoon; Hyun-Soo Kim; Yoo-Young Lee; Tae-Joong Kim; Chel-Hun Choi; Byoung-Gie Kim; Duk-Soo Bae; Ji Hye Hwang; Jeong-Won Lee
Journal:  Arch Gynecol Obstet       Date:  2015-07-09       Impact factor: 2.344
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.